anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

224,341-224,400 of 319,975

filter-aware
28
The slide uses a grid layout to display logos of various research and clinical partners.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
29
The slide uses a chevron-based timeline to distinguish between past achievements (checkmarks) and future goals (dots).NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
30
This is the final slide of the deck.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
31
The chart shows a clear divergence between the treatment and placebo groups over time, with error bars indicating variability.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
32
The chart highlights a 13.3% difference at the 180-day mark.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
33
The table includes adjusted means, 95% confidence intervals, p-values, and percentage differences for various ALS functional domains.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
01
Slide 1
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Problem1 hit
02
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Problem1 hit
03
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide uses a split layout: team members on the left and their associated track record (logos) on the right.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
05
The slide uses a timeline-based pipeline layout to show the progression of two drug candidates.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
06
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
Includes a detailed biological pathway diagram created with BioRender.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
The slide demonstrates superior tumor growth inhibition by NXP800 compared to Cisplatin in both resistant and sensitive models.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
Includes a patient MRI, a schematic of the PDX study design, a line chart showing tumor volume over time, and photographic evidence of tumor size reduction.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Market Size1 hit
11
The slide presents preclinical efficacy data for NXP800 in specific genetic subtypes of endometrial cancer.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Market Size1 hit
12
Includes footnotes regarding NGS panels and weighted average calculations.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Market Size1 hit
13
The slide uses a split-column layout to contrast two phases of a clinical trial.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
14
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
15
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
16
The charts are kinome dendrograms (KinomeScan style).Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · CompetitionLoop · Quick Win Big Bet1 hit
17
The slide uses a structural biology mechanism of action (MOA) comparison to demonstrate competitive advantage.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · CompetitionLoop · Quick Win Big Bet1 hit
18
Includes a biological pathway diagram, microscopy images, and an IC50 dose-response curve.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
The charts show tumor regression in NXP900 treated groups versus tumor growth in control groups over 27 days.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
Includes two distinct experimental setups: cell proliferation assays and mouse tumor growth models.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
21
The slide uses a structured table to segment market opportunity by biological markers.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
22
Clinical trial identifier NCT05873686 is provided.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
23
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Financials1 hit
24
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
25
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit
01
Slide 1
The slide features a branded orange banner across a closet image.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
02
Rent The Runway | Results Presentation Deck | 30 slidesRent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
03
The slide uses a 2x2 grid layout to present four key financial metrics over a four-year period.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · Problem1 hit
04
The slide uses a minimalist design with a large fashion photograph on the right.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · Problem1 hit
05
Rent The Runway | Results Presentation Deck | 30 slidesRent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · Problem1 hit
06
Includes definitions for subscriber metrics and the fiscal period end date.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · ProblemLoop · So What Cascade1 hit
07
The chart tracks subscriber trends for Rent the Runway, highlighting the split between active and paused users over time.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
08
The slide includes a note on fiscal year end dates and two key metrics regarding subscriber behavior.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
09
The slide uses a waterfall-bridge structure to visualize the components of gross profit.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
10
The slide uses a waterfall bridge format to show the components of EBITDA reconciliation.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
11
The slide uses a waterfall bridge to show the conversion of EBITDA to FCF, highlighting the impact of rental product purchases and other cash outflows.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
12
Rent The Runway | Results Presentation Deck | 30 slidesRent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
13
The slide uses two line charts with shaded areas to visualize the year-over-year improvement in churn metrics.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
The slide uses a mix of brand logos, fashion photography, and bulleted strategic benefits.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
Rent The Runway | Results Presentation Deck | 30 slidesRent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
Includes a screenshot of the mobile checkout flow as visual proof of the 'Buy Now' feature.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide uses a visual gallery of clothing styles to illustrate the performance improvement.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
Rent The Runway | Results Presentation Deck | 30 slidesRent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
19
Includes footnotes regarding non-GAAP reconciliation and rental product accounting.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
20
Rent The Runway | Results Presentation Deck | 30 slidesRent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
21
Includes a reconciliation of restructuring-related items.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
22
Financial data presented in millions.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
23
Includes both current and non-current restricted cash.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
24
Includes a footnote explaining specific adjustments for the years ended 1/31/23, 1/31/22, and 1/31/21.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
25
The table presents cash flow data in millions for nine-month periods ending Oct 31, 2023/2022 and the fiscal year ended Jan 31, 2023.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
26
The table reconciles cash-based 'Purchases of rental product' to accrual-based 'Rental Product Acquired' by adjusting for timing differences in receipt and payment.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
27
Includes specific adjustments like share-based compensation, depreciation, and restructuring charges.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
28
Includes data for nine-month periods and full fiscal years.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit
29
Includes footnotes explaining non-recurring and other adjustments.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 1 hit